Holen Sie sich die Stockscreener-App
580.41
2.55%
14.44
Handel nachbörslich:
580.41
Regeneron Pharmaceuticals Inc Aktie (REGN) Neueste Nachrichten
Russell Investments Group Ltd. Grows Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) Coverage Initiated at Rothschild & Co Redburn - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Public Sector Pension Investment Board - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Invesco Ltd. - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stake Boosted by Independent Advisor Alliance - MarketBeat
Cary Street Partners Financial LLC Sells 959 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron and Intellia’s Gene Therapy Study for Hemophilia B: A Potential Game Changer - TipRanks
Can Eylea HD and Dupixent Profits Revive Regeneron Stock? - Nasdaq
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat
Sienna Gestion Sells 566 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
National Pension Service Purchases 20,596 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Gulf International Bank UK Ltd Sells 2,097 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Mizuho Securities USA LLC Cuts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
How Will Regeneron’s (REGN) Solid Earnings and R&D Progress Shape Its Risk-Reward Balance? - simplywall.st
Michael Burry's Scion starts new position in UnitedHealth, lululemon and Regeneron among top Q2 moves - MSN
Nuveen LLC Purchases Shares of 542,018 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Aigen Investment Management LP Has $1.69 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Townsquare Capital LLC Boosts Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Entropy Technologies LP - MarketBeat
Ex-Dividend Reminder: ONE Gas, iRadimed and Regeneron Pharmaceuticals - Nasdaq
Regeneron and Intellia’s Phase 3 Study on NTLA-2001: A Potential Game-Changer for ATTRv-PN - TipRanks
Regeneron stock price target maintained at $780 by TD Cowen on pipeline strength - Investing.com Canada
Rothschild bullish on Regeneron as pipeline strength outweighs Eylea decline - Investing.com Canada
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by E Fund Management Co. Ltd. - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Tokio Marine Asset Management Co. Ltd. - MarketBeat
S Bank Fund Management Ltd Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Resona Asset Management Co. Ltd. Acquires 1,225 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Rothschild Redburn initiates Regeneron stock with Buy rating, $890 target By Investing.com - Investing.com Canada
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by National Bank of Canada FI - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Holdings Decreased by Swiss National Bank - MarketBeat
Fund Update: DODGE & COX added 1,502,198 shares of REGENERON PHARMACEUTICALS (REGN) to their portfolio - Quiver Quantitative
Citizens Financial Group Inc. RI Sells 465 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
BMO Capital Lifts PT on Regeneron Pharmaceuticals (REGN) Stock, Keeps Outperform - MSN
Regeneron Pharmaceuticals shares rise 1.12% intraday after Metagenomi reported positive business updates and financial results. - AInvest
Regeneron and Intellia’s Gene Therapy Study for Hemophilia B: A Potential Game-Changer? - TipRanks
Cantor Fitzgerald maintains Regeneron stock rating despite mixed update By Investing.com - Investing.com Canada
Here’s Why You Should Consider Buying Regeneron Pharma (REGN)’s Shares - Insider Monkey
Is Regeneron Pharmaceuticals (REGN) a Discounted Biotech Powerhouse With Long-Term Buy Potential? - AInvest
Lead Plaintiff Appointed in Regeneron Pharmaceuticals Class Action - TradingView
Charles Schwab Investment Management Inc. Raises Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Deutsche Bank AG Has $344.45 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Forsta AP Fonden Sells 1,300 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Maryland State Retirement & Pension System Cuts Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Reveals The Regeneron Prize For Creative Innovation 2025 Winners - MSN
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Amphastar Pharmaceuticals, QuidelOrtho, Integra LifeSciences, Select Medical, and Regeneron Stocks Trade Up, What You Need To Know - FinancialContent
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00 - MarketBeat
Sanofi halts China sales of cholesterol drug Praluent (SNY) - Seeking Alpha
Guggenheim Lifts PT on Regeneron Pharmaceuticals (REGN) to $815 From $810 - MSN
Knott David M Jr Takes $1.27 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by AIA Group Ltd - MarketBeat
Sanofi stops supply of high cholesterol drug to China due to limited availability - The Mighty 790 KFGO
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):